CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment

British Journal of Clinical Pharmacology

Volumn 80, Issue 2, 2015, Pages 193-199

  Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BBB; CGRP; CGRP receptor; CLR; gepants; monoclonal antibodies

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; TELCAGEPANT; TRIPTAN DERIVATIVE; ANALGESIC AGENT; CALCITONIN GENE RELATED PEPTIDE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DRUG EFFICACY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROIMAGING; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSFORMED MIGRAINE; TRIGEMINUS GANGLION; ANTAGONISTS AND INHIBITORS; METABOLISM; MIGRAINE DISORDERS;

ANALGESICS; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD-BRAIN BARRIER; CALCITONIN GENE-RELATED PEPTIDE; CLINICAL TRIALS AS TOPIC; HUMANS; MIGRAINE DISORDERS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; TRIGEMINAL GANGLION;

EID: 84937517146     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12618     Document Type: Article

References (73)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF,. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343-9.
2. Akerman S, Holland PR, Goadsby PJ,. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011; 12: 570-84.
3. Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ,. Brain activation in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014; 137: 232-41.
4. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ,. Oral triptans (serotonin 5-HT (1B/1D) agonists in the acute migraine treatment: a metaanalysis of 53 triptan trials. Lancet 2001; 358: 1668-75.
5. Tfelt-Hansen P., Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment. J Headache Pain 2011; 12: 275-80.
6. Dodick DW, Martin VT, Smith T, Silberstein S,. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 2004; 44 Suppl 1: S20-30.
7. 7, Edvinsson L, Linde M,. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet 2010; 376: 645-55.
8. Ho TW, Edvinsson L, Goadsby PJ,. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 2010; 6: 573-82.
9. Edvinsson L, Chan KY, Eftekhari S, Nilsson E, de Vries R,., Säveland H, Dirven CMF, Danser AHJ, MaassenVanDenBrink A,. Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 2010; 30: 1233-40.
10. Chan KY, Edvinsson L, Eftekhari S, Kimblad PO, Kane SA, Lynch J, Hargreaves RJ, de Vries R, Garrelds IM, van den Bogaerdt AJ, Danser AHJ, MaassenVanDenBrink A,. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther 2010; 334: 746-52.
11. Gupta S, Mehrotra S, Avezaat CJJ, Villalõn CM, Saxena PR, MaassenVanDenBrink A,. Characterization of CGRP receptors in the human isolated middle meningeal artery. Life Sci 2006; 79: 265-71.
12. Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D,. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology 2014; 83: 958-66.
13. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD,. Chronic migraine-classification, characteristics and treatment. Nat Rev Neurol 2012; 8: 162-71.
14. Dodick DW, Goadsby PJ, Spierings ELH, Scherer JC, Sweeney SP, Grayzel DS,. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol 2014; 13: 885-92.
15. Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J, for the ALD403 study investigarors. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol 2014; 13: 1100-7.
16. Bigal ME, Walter S,. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity. CNS Drugs 2014; 28: 389-99.
17. Edvinsson L, Ho TW,. CGRP receptor antagonism and migraine. Neurotherapeutics 2010; 7: 164-75.
18. Sur C, Hargreaves R, Bell I, Dancho M, Graham S, Hostetler E, Kane S, Kim J, Michener M, Miller P, O'Malley S, Salvatore C, Selnick H, Staas D, Stump C, Williams D, Wood M, Zeng Z, Cook J,. CSF levels and binding pattern of novel CGRP receptor antagonists in rhesus monkey and human central nervous system: toward the development of a PET tracer. Cephalalgia 2009; 29 (Suppl 1): 136-7.
19. Black JW, Leff L,. Operational models of pharmacological agonism. Proc R Soc Lond 1983; 220: 141-62.
20. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-7.
21. Cady RK, Vause CV, Ho TW, Bigal ME, Durham PL,. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache 2009; 49: 1258-66.
22. Goadsby PJ, Edvinsson L,. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33: 48-56.
23. Edvinsson L, Ekman R, Goadsby PJ,. Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia 2010; 30: 761-6.
24. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J,. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 2005; 58: 561-8.
25. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM,. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004; 350: 1104-10.
26. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J,. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985; 62: 131-6.
27. Uddman R, Edvinsson L, Hara H,. Axonal tracing of autonomic nerve fibers to the superficial temporal artery in the rat. Cell Tissue Res 1989; 256: 559-65.
28. Uddman R, Hara H, Edvinsson L,. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst 1989; 26: 69-75.
29. Edvinsson L, Hara H, Uddman R,. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides. J Cereb Blood Flow Metab 1989; 9: 212-8.
30. Liu Y, Broman J, Edvinsson L,. Central projections of the sensory innervation of the rat middle meningeal artery. Brain Res 2008; 1208: 103-10.
31. Liu Y, Broman J, Edvinsson L,. Central projections of sensory innervation of the rat superior sagittal sinus. Neuroscience 2004; 129: 431-7.
32. Liu Y, Zhang M, Broman J, Edvinsson L,. Central projections of sensory innervation of the rat superficial temporal artery. Brain Res 2003; 966: 126-33.
33. Arbab MA, Delgado T, Wiklund L, Svendgaard NA,. Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study. J Cereb Blood Flow Metab 1988; 8: 54-63.
34. Edvinsson L, Uddman R,. Neurobiology in primary headaches. Brain Res Rev 2005; 48: 438-56.
35. Edvinsson L., Tracing neural connections to pain pathways with relevance to primary headaches. Cephalalgia 2011; 31: 737-47.
36. McCulloch J, Uddman R, Kingman T, Edvinsson L,. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986; 83: 5731-5.
37. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM,. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-9.
38. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM,. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000; 275: 31438-43.
39. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C,. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 1995; 58: 213-7.
40. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG,. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002; 22: 620-9.
41. Sexton PM, McKenzie JS, Mendelsohn FA,. Evidence for a new subclass of calcitonin/calcitonin gene-related peptide binding site in rat brain. Neurochem Int 1988; 12: 323-35.
42. Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L,. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 2013; 14: 1289-303.
43. Eftekhari S, Edvinsson L,. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 2011; 12: 112.
44. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K,. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008; 507: 1277-99.
45. Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L,. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 2010; 169: 683-96.
46. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC,. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1: 658-60.
47. Lakhan SE, Avramut M, Tepper SJ,. Structural and functional neuroimaging in migraine: insights from 3 decades of research. Headache 2013; 53: 46-66.
48. Sexton PM,. Central nervous system binding sites for calcitonin and calcitonin gene-related peptide. Mol Neurobiol 1991; 5: 251-73.
49. Eftekhari S, Gaspar RC, Roberts R, Chen T, Zeng Z, Villarreal S, Edvinsson L, Salvatore CA,. Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: a detailed study using in situ hybridization, immunofluorescence and autoradiography. J Comp Neurol 2015; 000: 00-00.
50. Strata P, Thach WT, Ottersen OP,. New insights in cerebellar function. Neuroscience 2009; 162: 545-8.
51. Edvinsson L, Eftekhari S, Salvatore CA, Warfvinge K,. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat. Mol Cell Neurosci 2010; 46: 333-9.
52. Eftekhari S, Salvatore CA, Gaspar RC, Roberts R, O'Malley S, Zeng Z, Edvinsson L,. Localization of CGRP receptor components, CGRP, and receptor binding sites in human and rhesus cerebellar cortex. Cerebellum 2013; 12: 937-49.
53. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ,. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016-7.
54. Hostetler ED, Joshi AD, Sanabria-Bohorquez S, Fan H, Zeng Z, Purcell M, Gantert L, Riffel K, Williams M, O'Malley S, Miller P, Selnick HG, Gallicchio SN, Bell IM, Salvatore C, Kane SA, Li CC, Hargreaves R, de Groot T, Bormans G, Van Hecken A, Derdelinckx I, de Hoon J, Reynders T, Declercq R, De Lepeleire I, Kennedy WD, Blanchard R, Marcantonio EE, Sur C, Cook JJ, van Laere K, Evelhoch JL,. In vivo quantification of calcitonin gene-related peptide (CGRP) receptor occupancy by telcagepant in rhesus monkey and human brain usin the positron emission tomography (PET) tracer [11C]MK-4232. J Pharmacol Exp Ther 2013; 347: 478-86.
55. Edvinsson L, Nilsson E, Jansen-Olesen I,. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 2007; 150: 633-40.
56. Hoffmann J, Wecker S, Neeb L, Dirnagl U, Reuter U,. Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF. Cephalalgia 2012; 32: 659-67.
57. Asghar MS, Hansen AE, Amin FM, van der Geest RJ, van der Koning P, Larsson HBW, Olesen J, Ashina M,. Evidence for a vascular factor in migraine. Ann Neurol 2011; 69: 635-45.
58. Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJH, Larsson HBW, Olesen J, Ashina M,. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol 2013; 12: 454-61.
59. Juhl L, Edvinsson L, Olesen J, Jansen-Olesen I,. Effect of two novel CGRP-binding compounds in a closed cranial window rat model. Eur J Pharmacol 2007; 567: 117-24.
60. Hoehlig K, Johnson K, Pryazhnikov E, Maasch C, Clemens-Smith A, Purschke W, Vauléon S, Buchner K, Jarosch F, Khiroug L, Vater A, Klussmann S,. A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation. Br J Pharmacol 2015; doi: 10.1111/bph.13110.
61. Triguero DI, Buciak JB, Yang J, Pardridge WM,. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A 1989; 86: 4761-5.
62. Zlokovic BVI, Skundric DS, Segal MB, Lipovac MN, Mackic JB, Davson H,. A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Exp Neurol 1990; 107: 263-70.
63. Pardridge WMI, Kang YS, Buciak JL, Yang J,. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res 1995; 12: 807-16.
64. Bito LZ, Davson H, Hollingsworth JR,. Facilitated transport of prostaglandins across the blood-cerebrospinal fluid and blood-brain barrier. J Physiol 1976; 256: 273-85.
65. Edvinsson L, MacKenzie ET, McCulloch J,. Cerebral Blood Flow and Metabolism. Raven Press, New York, 1993: 1-683.
66. Eftekhari S, Salvatore CA, Johansson S, Chen T, Zeng Z, Edvinsson L. Localization of CGRP, CGRP receptor, PACAP and glutamate in rhesus monkey trigeminal ganglion. Relation to the blood-brain barrier. Brain Res 2015; 1600: 93-109.
67. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R,. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 1987; 7: 720-8.
68. Lundberg C, Haanes K, Grände G, Edvinsson L,. Microvascular passage and calculation of the transfer constant (Ki) for [51Cr]EDTA and water content following dural application of Freud's Adjuvant or Inflammatory Soup in trigeminal ganglion and CNS of rat. Cephalalgia 2015; 35 (Suppl. 1): 00.
69. Kaube H, Hoskin KL, Goadsby PJ,. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol 1993; 109: 788-92.
70. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA,. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004; 113: 1447-55.
71. Cutrer FM, Sorensen AG, Weisskoff RM, Ostergaard L, Sanchez del Rio M, Lee EJ, Rosen BR, Moskowitz MA,. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998; 43: 25-31.
72. Jager HR, Giffin NJ, Goadsby PJ,. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 2005; 25: 323-32.
73. Sanchez del Rio M, Bakker D, Wu O, Aosti R, Mitsikostas DD, Ostergaard L, Wells WA, Rosen BR, Sorensen G, Moskowitz MA, Cutrer FM,. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999; 19: 701-7.